Case Report: Early-onset or recalcitrant cytopenias as presenting manifestations of activated PI3Kδ syndrome
These cases highlight the importance of early genetic evaluation in patients with early-onset or recalcitrant cytopenias and demonstrate the challenges of differential diagnosis. In addition, these cases demonstrate beneficial changes in management and outcomes that can follow a definitive diagnosis, including the identification of targeted treatment options. Collectively, this case series supports the notion that underlying IEIs should be considered in the workup of early-onset or recalcitrant cytopenias, particularly in patients who present with a combination of hematologic and immunologic manifestations that are refractory to treatment, manifest at an unusually young age, or can be tied to family history.
Authors
- Irina Pateva
- Allison Remiker
- Rohith Jesudas (ORCID: https://orcid.org/0000-0002-9481-2581)
- Nami Park
- João Pedro Lopes (ORCID: https://orcid.org/0000-0002-9695-2932)
- Alexandra Superdock
Institutions
- Children's Hospital of Wisconsin (US)
- St. Jude Children's Research Hospital (US)
- United States Food and Drug Administration (US)
- Medical College of Wisconsin (US)
- Rainbow Babies & Children's Hospital (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2024-11-27
- DOI
- https://doi.org/10.3389/fped.2024.1494945
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00